Cargando…
Vitamin D status and hypertension: a review
Vitamin D is a steroid prohormone synthesized in the skin following ultraviolet exposure and also achieved through supplemental or dietary intake. While there is strong evidence for its role in maintaining bone and muscle health, there has been recent debate regarding the role of vitamin D deficienc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396645/ https://www.ncbi.nlm.nih.gov/pubmed/25897260 http://dx.doi.org/10.2147/IBPC.S49958 |
_version_ | 1782366612493434880 |
---|---|
author | Ke, Liang Mason, Rebecca S Kariuki, Maina Mpofu, Elias Brock, Kaye E |
author_facet | Ke, Liang Mason, Rebecca S Kariuki, Maina Mpofu, Elias Brock, Kaye E |
author_sort | Ke, Liang |
collection | PubMed |
description | Vitamin D is a steroid prohormone synthesized in the skin following ultraviolet exposure and also achieved through supplemental or dietary intake. While there is strong evidence for its role in maintaining bone and muscle health, there has been recent debate regarding the role of vitamin D deficiency in hypertension based on conflicting epidemiological evidence. Thus, we conducted a scoping systematic literature review and meta-analysis of all observational studies published up to early 2014 in order to map trends in the evidence of this association. Mixed-effect meta-analysis was performed to pool risk estimates from ten prospective studies (n=58,262) (pooled risk for incident hypertension, relative risk [RR] =0.76 (0.63–0.90) for top vs bottom category of 25-hydroxyvitamin D [25OHD]) and from 19 cross-sectional studies (n=90,535) (odds ratio [OR] =0.79 (0.73–0.87)). Findings suggest that the better the assessed quality of the respective study design, the stronger the relationship between higher 25OHD levels and hypertension risk (RR =0.67 (0.51–0.88); OR =0.77 (0.72–0.89)). There was significant heterogeneity among the findings for both prospective and cross-sectional studies, but no evidence of publication bias was shown. There was no increased risk of hypertension when the participants were of older age or when they were vitamin D deficient. Younger females showed strong associations between high 25OHD levels and hypertension risk, especially in prospective studies (RR =0.36 (0.18–0.72); OR =0.62 (0.44–0.87)). Despite the accumulating evidence of a consistent link between vitamin D and blood pressure, these data are observational, so questions still remain in relation to the causality of this relationship. Further studies either combining existing raw data from available cohort studies or conducting further Mendelian analyses are needed to determine whether this represents a causal association. Large randomized controlled trials are also needed to determine whether vitamin supplementation may be beneficial in the prevention or the treatment of hypertension. |
format | Online Article Text |
id | pubmed-4396645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43966452015-04-20 Vitamin D status and hypertension: a review Ke, Liang Mason, Rebecca S Kariuki, Maina Mpofu, Elias Brock, Kaye E Integr Blood Press Control Review Vitamin D is a steroid prohormone synthesized in the skin following ultraviolet exposure and also achieved through supplemental or dietary intake. While there is strong evidence for its role in maintaining bone and muscle health, there has been recent debate regarding the role of vitamin D deficiency in hypertension based on conflicting epidemiological evidence. Thus, we conducted a scoping systematic literature review and meta-analysis of all observational studies published up to early 2014 in order to map trends in the evidence of this association. Mixed-effect meta-analysis was performed to pool risk estimates from ten prospective studies (n=58,262) (pooled risk for incident hypertension, relative risk [RR] =0.76 (0.63–0.90) for top vs bottom category of 25-hydroxyvitamin D [25OHD]) and from 19 cross-sectional studies (n=90,535) (odds ratio [OR] =0.79 (0.73–0.87)). Findings suggest that the better the assessed quality of the respective study design, the stronger the relationship between higher 25OHD levels and hypertension risk (RR =0.67 (0.51–0.88); OR =0.77 (0.72–0.89)). There was significant heterogeneity among the findings for both prospective and cross-sectional studies, but no evidence of publication bias was shown. There was no increased risk of hypertension when the participants were of older age or when they were vitamin D deficient. Younger females showed strong associations between high 25OHD levels and hypertension risk, especially in prospective studies (RR =0.36 (0.18–0.72); OR =0.62 (0.44–0.87)). Despite the accumulating evidence of a consistent link between vitamin D and blood pressure, these data are observational, so questions still remain in relation to the causality of this relationship. Further studies either combining existing raw data from available cohort studies or conducting further Mendelian analyses are needed to determine whether this represents a causal association. Large randomized controlled trials are also needed to determine whether vitamin supplementation may be beneficial in the prevention or the treatment of hypertension. Dove Medical Press 2015-04-08 /pmc/articles/PMC4396645/ /pubmed/25897260 http://dx.doi.org/10.2147/IBPC.S49958 Text en © 2015 Ke et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Ke, Liang Mason, Rebecca S Kariuki, Maina Mpofu, Elias Brock, Kaye E Vitamin D status and hypertension: a review |
title | Vitamin D status and hypertension: a review |
title_full | Vitamin D status and hypertension: a review |
title_fullStr | Vitamin D status and hypertension: a review |
title_full_unstemmed | Vitamin D status and hypertension: a review |
title_short | Vitamin D status and hypertension: a review |
title_sort | vitamin d status and hypertension: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396645/ https://www.ncbi.nlm.nih.gov/pubmed/25897260 http://dx.doi.org/10.2147/IBPC.S49958 |
work_keys_str_mv | AT keliang vitamindstatusandhypertensionareview AT masonrebeccas vitamindstatusandhypertensionareview AT kariukimaina vitamindstatusandhypertensionareview AT mpofuelias vitamindstatusandhypertensionareview AT brockkayee vitamindstatusandhypertensionareview |